Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

(1) Background: This study aimed to develop a comprehensive understanding of the treatment-related adverse events when using PD-1 or PD-L1 inhibitors in triple-negative breast cancer (TNBC). (2) Methods: We conducted a meta-analysis of Phase II/III randomized clinical trials. Studies were searched f...

Celý popis

Podrobná bibliografie
Hlavní autoři: Yixi Zhang, Jingyuan Wang, Taobo Hu, Huina Wang, Mengping Long, Baosheng Liang
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2022-11-01
Edice:Life
Témata:
triple-negative breast cancer
PD-1 inhibitors
PD-L1 inhibitors
adverse events
safety
On-line přístup:https://www.mdpi.com/2075-1729/12/12/1990

Internet

https://www.mdpi.com/2075-1729/12/12/1990

Podobné jednotky